Skin Cancer, S Sunscreen, a and T Tips for Su Success i in M - - PowerPoint PPT Presentation

skin cancer s sunscreen a and t tips for su success i in
SMART_READER_LITE
LIVE PREVIEW

Skin Cancer, S Sunscreen, a and T Tips for Su Success i in M - - PowerPoint PPT Presentation

Skin Cancer, S Sunscreen, a and T Tips for Su Success i in M Managing Com ommon Ra Rashes i in Y our Clinic Brittney Schultz, M D Assistant Professor of Dermatology University of M innesota August 18, 2019 Objec ectives es


slide-1
SLIDE 1

Skin Cancer, S Sunscreen, a and T Tips for Su Success i in M Managing Com

  • mmon Ra

Rashes i in Y

  • ur Clinic

Brittney Schultz, M D Assistant Professor of Dermatology University of M innesota August 18, 2019

slide-2
SLIDE 2

Objec ectives es

  • Identify common skin cancers and choose appropriate biopsy

techniques for diagnosis

  • Discuss proper use of sunscreen and evaluate recent sunscreen

controversies in the media

  • Diagnose common rashes in clinic and determine appropriate

treatment

slide-3
SLIDE 3

Discl closures

  • No financial disclosures
  • No off-label use of medications
slide-4
SLIDE 4

Skin C Cancer: r: It’s a a problem!

Basal cell carcinoma Squamous cell carcinoma M elanoma

Image source: VisualDx.com

slide-5
SLIDE 5

Skin C Cancer r in M Minnesota

Source: M innesota Department of Health

slide-6
SLIDE 6

Skin C Cancer r in M Minnesota

Source: M innesota Department of Health

slide-7
SLIDE 7

Clues t to Skin C Cancer

Size M atter! S ymptoms

slide-8
SLIDE 8

Clues t to Skin C Cancer: r: B Basal cell c carcinoma

  • Painful
  • Growing
  • Bleeding
  • Shiny
  • Ulcerated
  • Prominent vessels
  • Scaly red patches
  • Scar-like
  • Can have pigment!

Image source: VisualDx.com

slide-9
SLIDE 9

Clues es to Skin Cancer er: S Squamous c cel ell carcinoma

  • Painful
  • Growing
  • Bleeding
  • Pink bumps
  • Red patches
  • Scaly
  • Can develop quickly

Image source: VisualDx.com

slide-10
SLIDE 10

Clues t to Skin C Cancer: r: M Melanoma

  • Painful
  • Growing
  • Bleeding
  • Changing
  • “ Ugly ducking”
  • ABCDEs
  • Can be amelanotic

Image source: VisualDx.com

slide-11
SLIDE 11

Mimick ckers o s of S Ski kin Cance ancer

Dermal nevus Eczema Seborrheic keratosis

Image source: VisualDx.com

slide-12
SLIDE 12

He Heigh ghten en S Suspicion

  • n
  • Transplant patient
  • Immunosuppressed
  • Azathioprine
  • Voriconazole
  • HIV patient
  • Tanning bed use
  • Family history of melanoma
  • History of

radiation/ burns/chronic inflammation

https:/ /commons.wikimedia.org/ w/ index.php?curid=34547559

slide-13
SLIDE 13

Diagnosis of Skin Cancer

Biopsy!

slide-14
SLIDE 14

When t to Punch, When t to Shave…

slide-15
SLIDE 15

Ho How you

  • u wou
  • uld biop
  • psy t

this l lesion

  • n?

Image source: VisualDx.com

slide-16
SLIDE 16
slide-17
SLIDE 17

Ho How you

  • u wou
  • uld biop
  • psy t

this l lesion

  • n?

Image source: VisualDx.com

slide-18
SLIDE 18
slide-19
SLIDE 19

Ho How you

  • u wou
  • uld biop
  • psy t

this l lesion

  • n?

Image source: VisualDx.com

slide-20
SLIDE 20
slide-21
SLIDE 21

Biopsy: B Basal and Squamous Cell C Carcinoma

  • Shave most commonly

employed

  • Quicker
  • Less expensive
  • No suture closure
  • Can result in surrounding

erythema that creates an indistinct border and may result in larger than necessary excision/ treatment

  • Portion is adequate but ensure

adequate depth

  • Punch from center of lesion may

also have advantages

  • M ay better define the growth

pattern

  • E.g. micronodular, morpheaform, or

infiltrative features may only be present in deeper portions

  • Could change treatment

J Am Acad Dermatol. 2016 Jan;74(1):1-16; quiz 17-8.

slide-22
SLIDE 22

Biopsy: M Melanoma

  • Complete excision

recommended

  • Can be performed via

saucerization for macular lesions using 0.5-2 mm margins

  • Partial biopsy associated with

inaccurate diagnosis and staging

  • Concern for tumor colonization
  • f a deep punch biopsy but no

evidence this worsens prognosis

J Am Acad Dermatol. 2016 Jan;74(1):1-16; quiz 17-8.

slide-23
SLIDE 23

Biopsy: Le Lenti tigo Malig ligna

  • Size of lesion may preclude

complete excision

  • Broad thin shave biopsy or

multiple small shave biopsies recommended

Image source: VisualDx.com J Am Acad Dermatol. 2016 Jan;74(1):1-16; quiz 17-8.

slide-24
SLIDE 24

Sunscreen

slide-25
SLIDE 25

Sunscreen B Basics

  • Sun gives off UVA and UVB (and UVC)
  • UVA

aging, passes through windows

  • UVB

sunburn, does not pass through windows

  • SPF = Sun Protection Factor

No sunscreen 5 min 5 min x SPF 30 = 150 min SPF 30 SPF = M inimal erythema dose (protected) M inimal erythema dose (unprotected)

slide-26
SLIDE 26

Sunscreen B Basics

  • Physical blockers (inorganic)
  • Titanium dioxide
  • Zinc oxide
  • Chemical blockers (organic)
  • Oxybenzone
  • Avobenzone
  • Octisalate
  • Ensulizole
  • Octocrylene
  • Octinoxate

Scatter/ deflect UVA/ UVB Absorb UVA + UVB photochemical reaction to render ineffective

UVA/ UVB UVA/ UVB Not all protect against both UVA/ UVB

slide-27
SLIDE 27

Sunscreen B Basics

  • Use broad-spectrum (UVA and

UVB)

  • SPF 30 or higher
  • Waterproof
  • Apply 15 minutes before going
  • utside
  • Re-apply every 2 hours or after

sweating/swimming

  • M ost adults need 1 ounce to

cover entire body

  • Better yet…
  • Sun protective clothing
  • Avoid peak hours of sun (10 am to

2 pm)

  • Caution with water, snow, sand

Daylight = sunlight!

slide-28
SLIDE 28
slide-29
SLIDE 29

“Does sunscreen even work rk?”

slide-30
SLIDE 30

“Does sunscreen even work rk?”

  • Reduce UV exposure/sunburn? Y

es.

  • Reduce skin cancer? A little more complicated.
  • UV exposure definitively associated with skin cancer
  • Some studies demonstrate reduction of skin cancer with sunscreen use and some do

not, but overall quality of evidence has been poor

  • Bottom line: Probably yes but challenging to definitively prove
J Clin Oncol. 2011 Jan 20;29(3):257-63. J AM A Dermatol. 2018 Sep 1;154(9):1001-1009. Cochrane Database Syst Rev. 2016 Jul 25;7:CD011161.
slide-31
SLIDE 31

“I n need to get a a base t tan”

slide-32
SLIDE 32

“I n need to get a a base t tan”

  • Not true – every UV exposure is damaging your skin
  • “ Base tan” provides SPF 3
  • Reduces sun protection measures on vacation
  • Bottom line: No you don’t

J Am Acad Dermatol. 2005 Dec;53(6):1038-44.

No sunscreen 5 min 5 min x 3= 15 min

slide-33
SLIDE 33

“My vi vitamin D D is already low”

slide-34
SLIDE 34

“My vi vitamin D D is already low”

  • Sources of vitamin D: diet and sun exposure (UVB)
  • “ Exposure of 5% of uncovered body surface 2x/ week in summer may be

equivalent to intake of 430 IU of vitamin D daily; however, for a given surface area, a plateau is reached after 20 minutes”

  • 8 oz glass of milk: 100 IU
  • 3.5 oz salmon: 360 IU
  • Vitamin D supplements do not carry risk of skin cancer and

photoaging

  • Bottom line: Supplement J

J Am Acad Dermatol. 2005 M ay;52(5):868-76.

slide-35
SLIDE 35

“Su “Sunsc screens s are d e damagin ing c cor

  • ral r

l ree eefs”

slide-36
SLIDE 36

“Su “Sunsc screens s are d e damagin ing c cor

  • ral r

l ree eefs”

  • Organic (chemical) UV filters have been identified in water worldwide
  • Oxybenzone #1
  • Highest percutaneous absorption and identified in human urine, serum, and breast milk
  • Others: octocrylene, octinoxate, 4-methylbenzylidene camphor (4-M BC)
  • Also found in cosmetics, shampoos, fragrances, flavors
  • Difficult to remove from water supply
  • Hormonal effects have been reported, including antiandrogen and

both proestrogen and antiestrogen effects, but significance in humans unclear

J Am Acad Dermatol. 2019 Jan;80(1):266-271.

slide-37
SLIDE 37

“Su “Sunsc screens s are d e damagin ing c cor

  • ral r

l ree eefs”

  • In vitro, a species of green algae was exposed to varying levels of
  • xybenzone
  • Lowest levels ~similar to environment (0.01-0.1 parts per billion)
  • Highest up to 5000 parts per billion
  • Higher concentrations of oxybenzone

decrease chlorophyll content and growth

  • High concentrations of oxybenzone in fish species

decreased egg production and fewer hatchings

  • High concentrations of zinc oxide nanoparticles in vitro

bleaching (not seen with titanium dioxide)

J Am Acad Dermatol. 2019 Jan;80(1):266-271. Sci Total Environ. 2018 Oct 1;637-638:1279-1285.

slide-38
SLIDE 38

Oxybenzone Octinoxate

slide-39
SLIDE 39

Bottom line:

  • There is concerning data regarding chemical sunscreens and

nanoparticles, however, these were in vitro studies with much higher

concentrations that currently found in the water supply

  • Additional studies are needed
  • In meantime – safest thing to do is use physical sunscreens without

nanoparticles and continue using sun-protective clothing, seeking shade, etc.

“Su “Sunsc screens s are d e damagin ing c cor

  • ral r

l ree eefs”

slide-40
SLIDE 40

“Sunscreen een gets in you

  • ur blood
  • odstrea

eam”

slide-41
SLIDE 41

“Sunscreen een gets in you

  • ur blood
  • odstrea

eam”

J AM A. 2019 M ay 6. Epub ahead of print.

slide-42
SLIDE 42

“Sunscreen een gets in you

  • ur blood
  • odstrea

eam”

  • 24 participants
  • Randomized to 1 of 4 sunscreens: spray 1, spray 2, lotion, and cream
  • 2 mg of sunscreen per 1 cm2 was applied to 75% BSA 4 times daily for 4 days
  • 30 blood samples collected over 7 days
  • Not exposed to direct sunlight during this time period
  • Primary outcome = maximum plasma concentration of avobenzone
  • Secondary outcomes = maximum plasma concentrations of
  • xybenzone, octocrylene, and ecamsule
  • Particularly interested in 0.5 ng/ mL threshold (established by FDA for

potentially waiving nonclinical toxicology studies for sunscreens)

J AM A. 2019 M ay 6. Epub ahead of print.

slide-43
SLIDE 43

J AM A. 2019 M ay 6. Epub ahead of print.

slide-44
SLIDE 44

J AM A. 2019 M ay 6. Epub ahead of print.

slide-45
SLIDE 45

“Sunscreen een gets in you

  • ur blood
  • odstrea

eam”

  • Y

es but…

  • What does it mean?
  • What are the health effects of this?
  • Were this realistic conditions?

J AM A. 2019 M ay 6. Epub ahead of print.

slide-46
SLIDE 46

“Sunscreen een gets in you

  • ur blood
  • odstrea

eam”

  • FDA has proposed rule to update regulatory requirements for

sunscreen products in the US

  • Proposed classification of sunscreen ingredients
  • GRASE = generally recognized as safe and effective, does not need FDA

approval

  • Titanium dioxide, zinc oxide
  • Not GRASE (also not in US)
  • P

ABA, tolamine salicylate

  • Calling for more safety data on 12 ingredients before determining GRASE/ not

GRASE including oxybenzone, octinoxate, avobenzone, etc.

  • If not GRASE, needs FDA approval

“ Sunscreen FAQS.” J Am Acad Dermatol.

slide-47
SLIDE 47
slide-48
SLIDE 48

“Sunscreen een gets in you

  • ur blood
  • odstrea

eam”

Bottom line:

  • We don’t know what the significance of bloodstream absorption
  • means. The study did not prove these products are unsafe but they

do deserve additional investigation.

  • The FDA is investigating which sunscreens should be considered

GRASE and not GRASE. Any not GRASE products will need FDA

  • approval. Final decision TBD ~November 2019.
  • In meantime, if concerned, can use physical sunscreens and continue

using sun-protective clothing, seeking shade, etc.

slide-49
SLIDE 49

Future Directions

  • Additional studies investigating harms to coral reefs
  • Significance of bloodstream absorption and health effects
  • Some sunscreens may need FDA approval in future
  • In meantime, please keep protecting your skin!
slide-50
SLIDE 50

Tips for r Success i in Managing C Common Rashes in Y

  • ur

r Clinic

slide-51
SLIDE 51

Tip #1: Different a acne diff fferent t tre reatment

  • Comedonal acne
  • Retinoid, retinoid, retinoid
  • Tretinoin 0.025% cream
  • Adapalene 0.1% cream
  • Adapalene 0.1% gel (OTC) = Differin

Image source: VisualDx.com

slide-52
SLIDE 52

Tip #1: Different a acne diff fferent t tre reatment

  • Inflammatory acne
  • Clindamycin 0.1% lotion
  • Benzoyl peroxide 5% wash
  • Retinoid
  • If deep-seated, may need short

course of antibiotic (max 3-6 mo)

  • Doxycycline 100 mg BID for up to 3

months, then taper

  • Low threshold to refer for

isotretinoin

M ust use together, never topical abx alone resistance Image source: VisualDx.com

slide-53
SLIDE 53

Tip #1: Different a acne diff fferent t tre reatment

  • Hormonal acne
  • Jawline predominance, especially

women > 25 years old, flare with menses

  • OCP – anti-androgen progestin e.g.

drospirenone

  • FDA approved = Ortho Tri-Cyclen,

Estrostep, Y az, Loryna, and Beyaz

  • Spironolactone
  • Consider screening for PCOS

Image source: VisualDx.com

slide-54
SLIDE 54

Tip #1: Different a acne diff fferent t tre reatment

Image source: VisualDx.com

Comedonal

  • Retinoid

Inflammatory

  • Retinoid
  • Topical antibiotic + BP wash
  • M ay need oral antibiotic for

short courses

  • Low threshold to refer for

isotretinoin

Hormonal

  • OCP
  • Spironolactone
slide-55
SLIDE 55

Tip #2: Different r rosacea differ eren ent tre reatment

  • Erythematotelangiectatic rosacea
  • Flushing
  • No papules/ pustules
  • M etronidazole does not usually

help

  • Rx:
  • Photoprotection, gentle skin care
  • Avoid triggers
  • Alpha-agonists: brimonidine and
  • xymetazoline
  • PDL

Image source: VisualDx.com

slide-56
SLIDE 56

Tip #2: Different r rosacea differ eren ent tre reatment

  • Papulopustular rosacea
  • M etronidazole does help
  • Sometimes need oral antibiotics,

usually less than acne doses

  • Doxycycline 100 mg BID for 2

months, then taper to minimum dose

  • Role for demodex? Ivermectin

has been used

Image source: VisualDx.com

slide-57
SLIDE 57

Tip #2: Different r rosacea differ eren ent tre reatment

  • Rhinophymatous rosacea
  • Overgrowth of sebaceous glands
  • Retinoids – topical or oral
  • Surgical debulking
  • If ocular component, usually

need cyclosporine drops or oral antibiotics (low doses)

Image source: VisualDx.com

slide-58
SLIDE 58

Tip #3: When it’s not lupus, it’s probably seborrh rrheic d derm rmatitis o

  • r rosacea

Systemic lupus erythematosus Acute “ butterfly rash” Nasolabial fold sparing Seborrheic dermatitis Loves the nasolabial folds – also check scalp, ears, beard Greasy scale common

  • Rx. Ketoconazole cream or shampoo

Image source: VisualDx.com

slide-59
SLIDE 59

Tip #3: When it’s not lupus, it’s probably seborrh rrheic d derm rmatitis o

  • r rosacea

Systemic lupus erythematosus Acute “ butterfly rash” Nasolabial fold sparing Rosacea M ay see papules/ pustules Can be difficult – history most helpful

Image source: VisualDx.com

slide-60
SLIDE 60

Tip #4: Is it scabies?

  • Worried about scabies?
  • First…

put on gloves

  • Then check:
  • Volar wrists
  • Finger webs
  • Umbilicus
  • Genitalia
  • Breasts
  • Skin folds
  • If no rash there, probably not

scabies

Image source: VisualDx.com

slide-61
SLIDE 61

Tip #5: Atopic derm rmatitis u usually not influen enced ed by f food

  • od a

aller ergi gies es

  • Food allergies common in

patients with atopic dermatitis but rarely are they a cause/ trigger for atopic dermatitis

  • Clues to food allergy:
  • Urticaria
  • Angioedema
  • Worsening in atopic dermatitis

following exposure to allergen

  • Keep eating!
  • Pediatrics. 2014 Dec;134(6):e1735-44.

Image source: VisualDx.com

slide-62
SLIDE 62

Tip #6: We usually don’t find a cause f for r urticari ria

  • Urticaria
  • Acute: <6 weeks
  • Chronic: > 6 weeks
  • Associations
  • If chronic, possible increased risks of

thyroid disease, T1D, SLE, and RA

  • Rarely associated with periodic fever

syndromes

  • Eval
  • Careful ROS

consider CBC, CM P , TSH, ESR

  • Biopsy usually not helpful
  • Treatment
  • Antihistamines, antihistamines,

antihistamines

  • Avoid triggers (NSAIDs)

Image source: VisualDx.com J Am Acad Dermatol. 2018 Oct;79(4):599-614. Cetirizine 10-20 mg BID plus Fexofenadine 180 mg BID

  • Allergy. 2018 Jul;73(7):1393-1414.
slide-63
SLIDE 63

Tip #7: Know y your s r steroids (or r at least know

  • ne

e steroi

  • id from
  • m stron
  • ng, mod
  • der

erate, weak)

  • Ointment > cream > lotion
  • “Ointment is greasy but works better”
  • “ I’d rather give you use something you will actually use”
  • OTC hydrocortisone is like water, I’m not surprised when it doesn’t

work

  • Should have a good trial of twice daily for 2-3 weeks before someone “ fails”

something

  • If lesions are thick, they need more potent topical corticosteroids but

location needs to guide you

slide-64
SLIDE 64

Tip #7: Know y your s r steroids (or r at least know

  • ne

e steroi

  • id from
  • m stron
  • ng, mod
  • der

erate, weak)

  • Potencies simplified (disclaimer – over-simplified!)
  • Face and/or groin
  • Desonide 0.05% ointment
  • Hydrocortisone valerate 0.2% ointment
  • Trunk and extremities
  • Triamcinolone 0.1% ointment – our workhorse
  • Hands/ feet and thick lesions on trunk and extremities
  • Fluocinonide 0.05% ointment (Lidex)
  • Clobetasol 0.05% ointment (the strongest)
slide-65
SLIDE 65

Ti Tip #8: Pois

  • ison ivy n

nee eeds s 3 week eeks s of

  • f or
  • ral

l ster eroid ids s (if i it need eeds or

  • ral s

ster eroid ids a s at all)

  • If mild involvement

potent topical steroid

  • If more diffuse
  • ral steroids

reasonable

  • Need to continue for 3 weeks to

prevent rebound

  • 40 mg x 5 days
  • 30 mg x 5 days
  • 20 mg x 5 days
  • 10 mg x 5 days

Image source: VisualDx.com

slide-66
SLIDE 66

Tip #9: Don’t use c combination antifungal and topical steroid

If unsure, start with topical antifungal BID x 2 weeks Switch to steroid if not improved

slide-67
SLIDE 67

Tip p #10: #10: VisualDx Dx.com is your ur friend nd

slide-68
SLIDE 68

Take e Hom

  • me P

Poin

  • ints
  • When on the hunt for skin cancer, symptoms matter.
  • Never punch a melanoma!
  • Don’t stop using sunscreen. M ore studies needed on recently raised

concerns on environmental impact and blood absorption.

  • When in doubt, use physical sunscreens and other photoprotective

measures.

  • Acne and rosacea have differing subtypes, with differing treatments.
  • Don’t use topical steroid + topical antifungal.
  • It’s never lupus.
slide-69
SLIDE 69

Thank Y Y

  • u!

u!

bschultz@umn.edu

slide-70
SLIDE 70

Refer eren ences es

  • Antia et al. Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up. J Am Acad Dermatol. 2018 Oct;79(4):599-

614.

  • Corinaldesi et al. Impact of inorganic UV filters contained in sunscreen products on tropical stony corals (Acropora spp.). Sci Total
  • Environ. 2018 Oct 1;637-638:1279-1285.
  • Green et al. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011 Jan 20;29(3):257-63.
  • Elston DM , EJ Stratman, and SJ M iller. Skin biopsy: Biopsy issues in specific diseases. J Am Acad Dermatol. 2016 Jan;74(1):1-16; quiz

17-8.

  • Levine et al. The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. J Am Acad
  • Dermatol. 2005 Dec;53(6):1038-44.
  • Lim et al. Sunlight, tanning booths, and vitamin D. J Am Acad Dermatol. 2005 M ay;52(5):868-76.
  • Riegel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol. 2008

M ay;58(5 Suppl 2):S129-32.

  • Sanchez et al. Sun protection for preventing basal cell and squamous cell skin cancers. Cochrane Database S

yst Rev. 2016 Jul 25;7:CD011161.

  • Schneider SL and HW Lim. Review of environmental effects of oxybenzone and other sunscreen active ingredients. J Am Acad
  • Dermatol. 2019 Jan;80(1):266-271.
  • Sunscreen FAQs. American Academy of Dermatology. https:/ / www.aad.org/ media/stats/ prevention-and-care/sunscreen-faqs
  • Tollefson M M and AL Bruckner; Section on Dermatology. Atopic dermatitis: skin-directed management. Pediatrics. 2014

Dec;134(6):e1735-44.

  • Watts et al. Sunscreen Use and M elanoma Risk Among Y
  • ung Australian Adults. JAM A Dermatol. 2018 Sep 1;154(9):1001-1009.
  • Zuberbier et al. The EAACI/ GA²LEN/ EDF/ WAO guideline for the definition, classification, diagnosis and management of urticaria.
  • Allergy. 2018 Jul;73(7):1393-1414.